Impaired blood-brain barrier function in angiotensinogen-deficient mice

Nature Medicine

Volumn 4, Issue 9, 1998, Pages 1078-1080

  Kakinuma, Yoshihiko ^a,b   Hama, Hiroshi ^b   Sugiyama, Fumihiro ^c,d   Yagami, Ken Ichi ^c   Goto, Katsutoshi ^b   Murakami, Kazuo ^a,d   Fukamizu, Akiyoshi ^a,d,e  

^a Institute of Applied Biochemistry   (Japan)

^b Institute of Basic Medical Sciences   (Japan)

^c Laboratory Research Animal Center   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e NATL INST FOR ADV INTERDISC RES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; LAMININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN INJURY; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; COLD INJURY; CONTROLLED STUDY; CORRELATION FUNCTION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CELL ADHESION; CELLS, CULTURED; GLIAL FIBRILLARY ACIDIC PROTEIN; MICE; MICE, KNOCKOUT;

ANIMALIA;

EID: 0031720384     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/2070     Document Type: Article

References (25)

1. Nieto-Sampedro, M., Saneto, R.P., De Vellis, J. & Cotman, C.W. The control of glial populations in brain: Changes in astrocyte mitogenic and morphogenic factors in response to injury. Brain Res. 343, 320-328 (1985).
2. Norenberg, M.D. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53, 213-220 (1994).
3. Janzer, R.C. & Raff, M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325, 253-257 (1987).
4. Ludwin, SK. Reaction of oligodendrocytes and astrocytes to trauma and implantation. Lab. Invest. 53, 20-30 (1985).
5. Laywell, E.D. et al. Enhanced expression of the developmentally regulated extracellular matrix molecule tenasin following adult brain injury. Proc. Natl. Acad. Sci. USA 89, 2634-2638 (1992).
6. Reier, P.J. in Cell Biology and Pathology of Astrocytes (ed. Waxman, S.G.) 263-324 (Academic, Orlando, Florida 1986).
7. Stornetta, R.L., Hawelu-Johnson, C.L., Guyenet, P.G. & Lynch, K.R. Astrocytes synthesize angiotensinogen in brain. Science 242, 1444-1446 (1988).
8. Milsted, A., Barna, B.P., Ransohof, R.M., Brosnihan, K.B. & Ferrario, C.M. Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc. Natl. Acad. Sci. USA 87, 5720-5723 (1990).
9. Tanimoto, K. et al. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 269, 31334-31337 (1994).
10. Sugiyama, F. et al. Speedy backcrossing through in vitro fertilization, using prepubertal superovulation and neonatal death dependent on genetic background in angiotensinogen-deficient mice. Lab. Anim. Sci. 47, 545-548 (1997).
11. Chan, P.H., Longar, S. & Fishman, R.A. Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann. Neurol. 21, 540-547 (1987).
12. Hama, H. et al. Role of endothelin-1 in astrocyte responses after acute brain damage. J. Neurosci. Res. 47, 590-602 (1997).
13. Liedtke, W. et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17, 607-615 (1996).
14. Goldstein, G.W. & Betz, A.L. The blood-brain barrier. Sci. Am. 255, 70-83 (1986).
15. Le-Prince, G., Fages, C., Rolaand, B., Nunez, J. & Tardy, M. DBcAMP effect on the expression of GFAP and of its encoding mRNA in astroglial primary culture. Glia 4, 322-326 (1991).
16. Eng, L.F. & Ghirnikar, R.S. GFAP and astrogliosis. Brain Pathol. 4, 229-237 (1994).
17. Wright, J.W. et al. The angiotensin IV system: functional implications. Front. Neuroendocrinol. 16, 23-52 (1995).
18. Roberts, K.A. et al. Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res. 682, 13-21 (1995).
19. Miller-Wing, A.V., et al. Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J. Pharmacol. Exp. Ther. 266, 1718-1726 (1993).
20. Moeller, I. et al. Distribution of AT4 receptors in the Macaca fascicularis brain. Brain Res. 712, 307-324 (1996).
21. De Oliveira, A.M., Viswanathan, M., Heemskerk, F.M.J. & Saavedra, J.M. Expression of a novel angiotensin II receptor subtype in gerbil brain. Brain Res. 705, 177-187 (1995).
22. Shibouta, Y. et al. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylic acid (CV-11974), and its prodrug (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1 -[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7- carboxylate (TCV-116). J. Pharmacol. Exp. Ther. 266, 114-120 (1993).
23. Dudley, D.T. et al. Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol. 38, 370-377 (1990)
24. Wright, J.W., Bechtholt, A.J., Chambers, S.L. & Harding, J.W. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function. Peptides 17, 1365-1371 (1996).
25. Warnick, R.E. et al. Measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity. J. Neurosci. Methods 58, 167-171 (1995).